Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lungfunction decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.
Article
CAS
PubMed
PubMed Central
Google Scholar
Walters JAE, Gibson PG, Wood-Baker R, Hannay M, Walters EH: Systemic corticosteroids for acute exacerbations of chronic pulmonary disease. Cochrane Database Syst Rev. 2009, 21: CD001288-
Google Scholar
Bathoorn E, Kerstjens H, Postma D, Timens W, MacNee W: Airways inflammation and treatment during acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2008, 3: 217-229.
PubMed
PubMed Central
Google Scholar
Vondracek S, Hemstreet BA: Retrospective evaluation of systemic corticosteroids for the management of acute exacerbations of chronic obstructive pulmonary disease. Am J Helath Syst Pharm. 2006, 63: 645-652. 10.2146/ajhp050316.
Article
CAS
Google Scholar
Smeele IJM, Van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer T, et al: NHG-Standaard COPD. Huisarts Wet. 2007, 50: 362-379.
Google Scholar
Braspenning JC, Schellevis FG, Grol RP: Second Dutch National survey of general practice. Eur J Publ Health. 2005, 15: 59-65.
Google Scholar
Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999, 354: 456-460. 10.1016/S0140-6736(98)11326-0.
Article
CAS
PubMed
Google Scholar
Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, et al: Effect of systemic glucocorticosteroids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1999, 340: 1941-1947. 10.1056/NEJM199906243402502.
Article
CAS
PubMed
Google Scholar
Aaron SD, VandemHeen KL, Hebert P, Dales R, Stiell IG, Ahuja J, Dickinson G, Brison R, Rowe BH, Dreyer J, Yetisir E, Class D, Wells G: Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003, 348: 2618-2625. 10.1056/NEJMoa023161.
Article
CAS
PubMed
Google Scholar
Sayiner A, Aytemur ZA, Cirtit M, Unsal I: Systemic glucocorticosteroids in severe exacerbations of COPD. Chest. 2001, 119: 726-730. 10.1378/chest.119.3.726.
Article
CAS
PubMed
Google Scholar
Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW: Oral or IV Prednisolone in the Treatment of COPD Exacerbations: a Randomized, Controlled, double-blind Study. Chest. 2007, 132: 1741-1747. 10.1378/chest.07-0208.
Article
PubMed
Google Scholar
Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, et al: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of Acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2002, 165: 698-703.
Article
PubMed
Google Scholar
Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E: The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J. 2007, 29: 660-667. 10.1183/09031936.00073506.
Article
CAS
PubMed
Google Scholar
Ställberg B, Selroos O, Vogelmeier C, Andersson E, Ekström T, Larsson K: Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. Respir Res. 2009, 10: 11-10.1186/1465-9921-10-11.
Article
PubMed
PubMed Central
Google Scholar
Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koeter GH, et al: Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. COPD. 2008, 5: 282-290. 10.1080/15412550802363360.
Article
PubMed
Google Scholar
O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Caroll KB, Woodcock AA: Double-blind trial of steroid tapering in acute asthma. Lancet. 1993, 341: 324-327. 10.1016/0140-6736(93)90134-3.
Article
PubMed
Google Scholar
Hurst JR, Wedzicha JA: Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J. 2004, 80: 497-505. 10.1136/pgmj.2004.019182.
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh JM, Palda VA, Stanbrook MB, Chapman KR: Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med. 2002, 162: 2527-2536. 10.1001/archinte.162.22.2527.
Article
CAS
PubMed
Google Scholar
Rodríguez-Roisin R: COPD exacerbations. 5: Management. Thorax. 2006, 61: 535-544. 10.1136/thx.2005.041863.
Article
PubMed
PubMed Central
Google Scholar
McCrory DC, Brown C, Gelfand SE, Bach PB: Management of acute exacerbations of COPD: A summary and Appraisal of Published Evidence. Chest. 2001, 119: 1190-1209. 10.1378/chest.119.4.1190.
Article
CAS
PubMed
Google Scholar
Fabbri L, Pauwels RA, Hurd SS, Pauwels S, et al: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003. COPD. 2004, 1: 105-141.
Article
PubMed
Google Scholar
Clore JN, Thurby-Hay L: Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009, 15: 469-474. 10.4158/EP08331.RAR.
Article
PubMed
Google Scholar
Burt MG, Roberts GW, Aguilar-Loza NR, Frith P, Stranks SN: Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. J Clin Endocrinol Metab. 2011, 96: 0000-0000.
Article
CAS
Google Scholar
Warrington TP, Bostwick JM: Psychiatric Adverse Effects of Corticosteroids. Mayo Clin Proc. 2006, 81: 1361-1367. 10.4065/81.10.1361.
Article
CAS
PubMed
Google Scholar
Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Nusbaumer C, Brutsche M, Müller B: Effect of a 14-day course of systemic corticosteroids on the hypothalamic pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2008, 8: 1-10.1186/1471-2466-8-1.
Article
PubMed
PubMed Central
Google Scholar
Buchman AL: Side Effects of Corticosteroid Therapy. J Clin Gastroenterol. 2001, 33: 289-294. 10.1097/00004836-200110000-00006.
Article
CAS
PubMed
Google Scholar
Schuets P, Leuppi JD, Tamm M, Briel M, Bingisser R, Durring U, Muller B, Schindler C, Viatte S, Rutishauser J: Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease. Swiss Med Wkly. 2010, 140: w13109-
Google Scholar
Chang AB, Clark R, Sloots TP, Stone DG, Petsky HL, Thearle D, Champion AA, Wheeler C, Acworth JP: A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. MJA. 2008, 189: 306-310.
PubMed
Google Scholar
Jones AM, Munavvar M, Vail A, Aldrige E, Hopkinson L, Rayner C, O' Driscoll BRO: Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respiratory Medicine. 2002, 96: 950-954. 10.1053/rmed.2002.1369.
Article
CAS
PubMed
Google Scholar